CIK 0001641631 · Non-accelerated filer<br>Smaller reporting company
Beyond Air, Inc.
Sign in to watch- Ticker
- XAIR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473812456
- Phone
- 516-665-8200
- Business address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530
- Former names
- AIT Therapeutics, Inc., KokiCare, Inc.
- Open-market buys, last 90 days
- $62,352
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,352. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +2,000 | 2,000 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −1,500 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +1,500 | 1,500 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −1,250 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +1,250 | 1,250 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −1,250 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +1,250 | 1,250 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −1,000 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +1,000 | 1,000 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −1,250 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +1,250 | 1,250 | ||
| 2025-11-04 | Lucera Erick Director | Returned to the company · Stock Options (Right to buy) | −3,750 | 0 | ||
| 2025-11-04 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +3,750 | 3,750 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −15,000 | 0 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +15,000 | 15,000 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −6,000 | 0 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +6,000 | 6,000 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −1,000 | 0 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +1,000 | 1,000 | ||
| 2025-11-04 | Larson Douglas Quinton Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −3,750 | 0 |
Page 4 of 17 · 328 trades